The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Melanoma, Experimental

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Melanoma, Experimental


High impact information on Melanoma, Experimental


Chemical compound and disease context of Melanoma, Experimental


Biological context of Melanoma, Experimental


Anatomical context of Melanoma, Experimental


Gene context of Melanoma, Experimental


Analytical, diagnostic and therapeutic context of Melanoma, Experimental


  1. Experimental metastasis correlates with cyclic AMP accumulation in B16 melanoma clones. Sheppard, J.R., Koestler, T.P., Corwin, S.P., Buscarino, C., Doll, J., Lester, B., Greig, R.G., Poste, G. Nature (1984) [Pubmed]
  2. Phenylthioalkylamines in experimental tumor treatment in mice. DiStefano, V., Evans, I., Myers-Robfogel, M., Estes, J., Godleski, S.A. J. Natl. Cancer Inst. (1983) [Pubmed]
  3. Modulation by taurine of the toxicity of taumustine, a compound with antitumor activity. Pierson, H.F., Fisher, J.M., Rabinovitz, M. J. Natl. Cancer Inst. (1985) [Pubmed]
  4. Additional antitumor ecteinascidins from a Caribbean tunicate: crystal structures and activities in vivo. Sakai, R., Rinehart, K.L., Guan, Y., Wang, A.H. Proc. Natl. Acad. Sci. U.S.A. (1992) [Pubmed]
  5. Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma. Eitzman, D.T., Krauss, J.C., Shen, T., Cui, J., Ginsburg, n.u.l.l. Blood (1996) [Pubmed]
  6. Reversion of the transformed phenotype of B16 mouse melanoma: involvement of an 83 kd cell surface glycoprotein in specific growth inhibition. Wieland, I., Müller, G., Braun, S., Birchmeier, W. Cell (1986) [Pubmed]
  7. Melanocyte-stimulating hormone promotes activation of pre-existing tyrosinase molecules in Cloudman S91 melanoma cells. Wong, G., Pawelek, J. Nature (1975) [Pubmed]
  8. Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Nakajima, M., Irimura, T., Di Ferrante, D., Di Ferrante, N., Nicolson, G.L. Science (1983) [Pubmed]
  9. Tumor suppression with a combination of alpha-difluoromethyl ornithine and interferon. Sunkara, P.S., Prakash, N.J., Mayer, G.D., Sjoerdsma, A. Science (1983) [Pubmed]
  10. Lysosomal cathepsin B: correlation with metastatic potential. Sloane, B.F., Dunn, J.R., Honn, K.V. Science (1981) [Pubmed]
  11. Macrophages elicited with heat-killed bacillus Calomette-Guérin protect C57BL/6J mice against a syngeneic melanoma. Freedman, V.H., Calvelli, T.A., Silagi, S., Silverstein, S.C. J. Exp. Med. (1980) [Pubmed]
  12. B16 melanoma cell variants: irreversible inhibition of growth and induction of morphologic differentiation by anthracycline antibiotics. Raz, A. J. Natl. Cancer Inst. (1982) [Pubmed]
  13. High levels of Met-72 antigen expression: correlation with metastatic activity of B16 melanoma tumor cell variants. Kimura, A.K., Xiang, J.H. J. Natl. Cancer Inst. (1986) [Pubmed]
  14. Characterization of the inhibitory effects of retinoids on the in vitro growth of two malignant murine melanomas. Lotan, R., Giotta, G., Nork, E., Nicolson, G.L. J. Natl. Cancer Inst. (1978) [Pubmed]
  15. Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens. Taniguchi, K., Petersson, M., Höglund, P., Kiessling, R., Klein, G., Kärre, K. Proc. Natl. Acad. Sci. U.S.A. (1987) [Pubmed]
  16. Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness. Sadahira, Y., Ruan, F., Hakomori, S., Igarashi, Y. Proc. Natl. Acad. Sci. U.S.A. (1992) [Pubmed]
  17. Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples. Morvan, D., Demidem, A., Papon, J., De Latour, M., Madelmont, J.C. Cancer Res. (2002) [Pubmed]
  18. Liposomal N,N,N-trimethylsphingosine (TMS) as an inhibitor of B16 melanoma cell growth and metastasis with reduced toxicity and enhanced drug efficacy compared to free TMS: cell membrane signaling as a target in cancer therapy III. Park, Y.S., Hakomori, S., Kawa, S., Ruan, F., Igarashi, Y. Cancer Res. (1994) [Pubmed]
  19. Gamma delta T cells provide an early source of interferon gamma in tumor immunity. Gao, Y., Yang, W., Pan, M., Scully, E., Girardi, M., Augenlicht, L.H., Craft, J., Yin, Z. J. Exp. Med. (2003) [Pubmed]
  20. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. van Elsas, A., Hurwitz, A.A., Allison, J.P. J. Exp. Med. (1999) [Pubmed]
  21. Selective degradation of basement membrane macromolecules by metastatic melanoma cells. Kramer, R.H., Vogel, K.G. J. Natl. Cancer Inst. (1984) [Pubmed]
  22. Effect of cell wall skeleton and monophosphoryl lipid A adjuvant on the immunogenicity of a murine B16 melanoma vaccine. Johnston, D., Bystryn, J.C. J. Natl. Cancer Inst. (1991) [Pubmed]
  23. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis. Conacci-Sorrell, M.E., Ben-Yedidia, T., Shtutman, M., Feinstein, E., Einat, P., Ben-Ze'ev, A. Genes Dev. (2002) [Pubmed]
  24. Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma. Tirapu, I., Huarte, E., Guiducci, C., Arina, A., Zaratiegui, M., Murillo, O., Gonzalez, A., Berasain, C., Berraondo, P., Fortes, P., Prieto, J., Colombo, M.P., Chen, L., Melero, I. Cancer Res. (2006) [Pubmed]
  25. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Murakami, T., Maki, W., Cardones, A.R., Fang, H., Tun Kyi, A., Nestle, F.O., Hwang, S.T. Cancer Res. (2002) [Pubmed]
  26. T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas. Böhm, W., Thoma, S., Leithäuser, F., Möller, P., Schirmbeck, R., Reimann, J. J. Immunol. (1998) [Pubmed]
  27. The inhibition of early N-glycan processing targets TRP-2 to degradation in B16 melanoma cells. Negroiu, G., Dwek, R.A., Petrescu, S.M. J. Biol. Chem. (2003) [Pubmed]
  28. Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model. Schreurs, M.W., Eggert, A.A., de Boer, A.J., Vissers, J.L., van Hall, T., Offringa, R., Figdor, C.G., Adema, G.J. Cancer Res. (2000) [Pubmed]
  29. Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa-levodopa methyl ester chemotherapy. Meadows, G.G., Pierson, H.F., Abdallah, R.M., Desai, P.R. Cancer Res. (1982) [Pubmed]
  30. Growth response of B16 melanoma to in vivo treatment with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) at the initial stage after tumor transplantation. Li, X.H., Paulus, G., Atassi, G., Buyssens, N. Am. J. Pathol. (1984) [Pubmed]
  31. Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells. Yu, J.S., Burwick, J.A., Dranoff, G., Breakefield, X.O. Hum. Gene Ther. (1997) [Pubmed]
  32. Adoptive immunotherapy of metastatic B16 melanoma with allogeneic immune cells sensitized to minor histocompatibility antigens. Beatty, P.A., Greenberg, P.D., Cheever, M.A. Transplantation (1985) [Pubmed]
WikiGenes - Universities